Artificial urinary sphincter: 11-year experience in adolescents with congenital neuropathic bladder

European Urology
P López PereiraEnrique Jaureguizar Monroe

Abstract

We assess our experience over the last 11 years in the use of an artificial urinary sphincter (AUS) to treat urinary incontinence in children with neuropathic bladders. Between 1994 and 2005 an AUS was implanted in 35 patients (mean age 14.4; range 11.5-18). Upper urinary tract (UUT) evaluations and urodynamic studies were performed in all patients pre- and post-AUS implantation. Thirteen patients underwent enterocystoplasty combined with AUS placement and 22 underwent AUS implantation alone. An AUS was implanted in 35 patients. Mean follow-up is 5.5 years (range 0.4-11 years). Nine mechanical malfunctions occurred in seven patients (20%). Of the 22 patients who underwent AUS implantation alone, seven (31.2%) eventually required an enterocystoplasty because of unexpected bladder behaviour changes, usually within three years of AUS implantation. In seven patients (20%), a continent catheterisable stoma was made (before or during the follow-up) because of problems with clean intermittent catheterisation (CIC) through the urethra. Three AUS (8.6%) were removed because of sphincter erosion at the bladder neck. All 32 patients (91.4%) with the AUS currently in place are dry, three void their bladders spontaneously, and 29 need CIC. ...Continue Reading

Citations

Mar 20, 2010·Der Urologe. Ausg. A·N DjakovicM Hohenfellner
Oct 23, 2012·The Journal of Urology·Ulrich MehnertEmmanuel Chartier-Kastler
Oct 20, 2010·The Urologic Clinics of North America·Arthur Mourtzinos, John T Stoffel
Aug 14, 2008·BJU International·Jürgen Pannek, Manfred Stöhrer
Mar 31, 2012·Neurourology and Urodynamics·L M O de KortS B Bauer
Jul 4, 2007·Expert Review of Medical Devices·Aza MohammedIslam Junaid
Apr 21, 2016·Current Opinion in Urology·Alonso Carrasco, Vijaya M Vemulakonda
May 27, 2020·Current Opinion in Urology·Fawzy FaragSalvador Arlandis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.